Comparisons between other doses also showed a trend towards a better effect at higher doses, but some results were limited by the wide CrIs.
← all excerpts
Assessing the Optimal Regimen: A Systematic Review and Network Meta-Analysis of the Efficacy and Safety of Long-Acting Granulocyte Colony-Stimulating Factors in Patients with Breast Cancer.
1
—
—